Press and Business Intelligence in Attendance at BioTrinity 2013

As well as being a great conference to partner, BioTrinity 2013 will be an opportunity to raise your profile in print and online by meeting with trade press that registered in recent years:
 
SCRIP (Informa), Biocentury, Nature Biotechnology, Clinica, Financial Times, In Vivo, MedNous, Mergermarket (FT Group), Innvaro Pharmalicensing (Innovaro Europe), Innovations in Pharmaceutical Technology (Samedan), Pharmafocus, The Pink Sheet, Biopharm Insight, Chemistry World, PharmaWire, R&D Focus (IMS Health), Drug Discovery Today, International Labmate, PharmaTV and Current Partnering

Press and Arranging Press Passes

All media relations for BioTrinity, including press registration, is coordinated by Citigate Dewe Rogerson, OBN’s media sponsor.

BioTrinity welcomes all journalists free of charge, particularly those writing for industry-specific news and publishing organisations.

In order to receive a Press Pass, journalists must contact Citigate Dewe Rogerson and will need to provide valid press credentials. The press pass will provide journalists with full access to BioTrinity including the partnering software to enable you to make meeting requests in advance of the conference.

For all media enquiries and to register as a journalist for BioTrinity contact Janine Hagan at Citigate Dewe Rogerson with your full contact details (including job title):

Janine Hagan
Citigate Dewe Rogerson
T: 020 7282 1068
Email: janine.hagan@citigatedr.co.uk

If you have any general questions regarding the event, please contact Jenny Hazelden

Please note that pre-registration is essential to gain entry to the conference. No badge - no entry! 

Press Area

A dedicated Press Area will be located within the main Exhibition Hall of the Grandstand. The Press Area, managed by Citigate, will be equipped with a PC and a printer and free wifi access will also be available.

We encourage all attending companies to display their Press Releases in the Press Area.



BioTrinity 2012 highlights
800 delegates from 26 countries
500 companies
130 speakers
75 company presentations
1850 scheduled one-to-one meetings
80 investors from 10 countries
69 exhibitors
22 global pharma